Riskpilot← Back to searchSign inGet full accessFoersom Genetik ApS
APSActiveCVR 24221512Lynggårdsvej 4Raising of swine and pigs · NACE 0146Est. 199918 employees
Revenue 2024
DKK 8,9M
+22% vs 2023
EBITDA margin
33.0%
+118% vs 2023
Equity ratio
86.5%
Financial strength
Net profit 2024
DKK 1,4M
+4641% vs 2023
| Revenue | DKK 8,9M | +22% |
| EBITDA | DKK 2,9M | +118% |
| Net profit | DKK 1,4M | +4641% |
| Total assets | DKK 30M | +2% |
| Equity | DKK 25,9M | +1% |
| Employees | 18 | — |
Legal name
Foersom Genetik ApS
CVR number
24221512
Legal form
Anpartsselskab
NACE code
0146 · Raising of swine and pigs
Founded
18. juni 1999
Share capital
DKK 125.000
Employees
18 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren alene
Company purpose
Selskabets formål er at drive landbrug og dermed beslægtet virksomhed
Address
Lynggårdsvej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7.169 | 5.805 | 1.885 | 7.294 | 8.922 |
| Staff expenses | -4.899 | -4.692 | -4.995 | -5.567 | -5.213 |
| EBITDA | 2.270 | 1.100 | -2.856 | 1.350 | 2.944 |
| Depreciation & amort. | -1.233 | -1.469 | -1.359 | -1.292 | -1.408 |
| EBIT | 1.037 | -368 | -4.215 | 58 | 1.536 |
| Net financials | -623 | 251 | 560 | 105 | 130 |
| Profit before tax | 414 | -118 | -3.655 | 163 | 1.666 |
| Tax | 186 | -111 | -868 | 134 | 286 |
| Net profit | 228 | -7 | -2.787 | 29 | 1.380 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 32.214 | 32.001 | 28.424 | 29.238 | 29.960 |
| Equity | 28.305 | 28.298 | 25.511 | 25.540 | 25.921 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.892 | 1.796 | 959 | 2.206 | 2.490 |
| Total debt | 1.892 | 1.796 | 959 | 2.206 | 2.490 |
EBITDA margin
33.0%
This company
15.8%
Market median
+109% vs market
20202024
Equity ratio
86.5%
This company
38.2%
Market median
+126% vs market
20202024
Return on equity
5.3%
This company
18.4%
Market median
-71% vs market
20202024
Net profit margin
15.5%
This company
8.1%
Market median
+91% vs market
20202024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AB Management | Management | 2024 |
AD Management | Management | 1999 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2024 | |
| Company | 50–66.65% | 50–66.65% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Foersom Holding ApS
Foersom Genetik ApS Board members of Foersom Genetik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Biltoft Houe Hansen | Management | 0 companies |
| Arne Damgaard | Management | 0 companies |